Next Article in Journal
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Previous Article in Journal
Modelling the Cost-Effectiveness of Hepatitis A in South Africa
 
 
Article

Article Versions Notes

Vaccines 2024, 12(2), 117; https://doi.org/10.3390/vaccines12020117
Action Date Notes Link
article xml file uploaded 24 January 2024 10:31 CET Original file -
article xml uploaded. 24 January 2024 10:31 CET Update https://www.mdpi.com/2076-393X/12/2/117/xml
article pdf uploaded. 24 January 2024 10:31 CET Version of Record https://www.mdpi.com/2076-393X/12/2/117/pdf
article html file updated 24 January 2024 10:32 CET Original file https://www.mdpi.com/2076-393X/12/2/117/html
Back to TopTop